medigraphic.com
ISSN 2992-7749 (Electronic)
ISSN 2992-7897 (Print)
Órgano Oficial de difusión científica de la Asociación Mexicana de Cirujanos de Columna A. C.

2025, Number 4

<< Back Next >>

Cir Columna 2025; 3 (4)

Vertebral destruction syndrome and its etiology in a third level hospital

González EG, Infante LCG, Gervacio GHC

Language: Spanish
References: 17
Page: 290-295
PDF size: 220.48 Kb.


ABSTRACT

Introduction: vertebral destruction syndrome is a pathology with multiple etiologies that causes structural alterations in the spine, specifically deformity with increased volume, which can cause mechanical and/or neurological compromise. Objetives: to show the incidence and etiology of vertebral destruction syndrome in patients at our institute. Material and methods: retrospective, observational, descriptive study. Inclusion criteria: patients of both sexes, over 18 years of age, with a confirmed diagnosis of vertebral destruction syndrome by histopathological report and laboratory and imaging studies, with a complete clinical record. Exclusion criteria: patients with incomplete clinical records and/or without valid rights, patients without results from the pathology service, patients who refused the treatment offered or did not have adequate adherence to the study protocol (three or more absences from scheduled appointments). Results: higher incidence for men with 34 cases and 17 cases diagnosed in the female gender, with an age range of 25 to 85 years with an average age of 64.66 years. Vertebral bodies most frequently affected: L4: 18 cases; L2: seven patients; L5: seven patients; L3 on 11 occasions. The first cause of vertebral destruction syndrome in our population was neoplastic origin with 34 cases confirmed with histopathological report, followed by infectious origin with nine cases and finally eight cases of metabolic origin. Conclusions: it is very important not to underestimate a case of low back pain and to carry out an adequate study of the symptoms to rule out this type of pathology.


REFERENCES

  1. Calvet M, Marqués A. Signos de alarma de la lumbalgia. Semin Fund Esp Reumatol. 2010; 11: 24-27. doi: 10.1016/j.semreu.2009.09.006.

  2. Sayed D, Grider J, Strand N, Hagedorn J, Falowski S, Lam C. The American Society of Pain and Neuroscience (ASPN) evidence-based clinical guideline of interventional treatments for low back pain. J Pain Res. 2022; 15: 3729-3832. doi: 10.2147/JPR.S386879.

  3. Crombé A, Fadli D, Clinca R. Imaging of spondylodiscitis: a comprehensive updated review—multimodality imaging findings, differential diagnosis, and specific microorganisms detection. Microorganisms. 2024; 12: 893. doi: 10.3390/microorganisms12050893.

  4. Shanmuganathan R, Ramachandran, K. Active tuberculosis of spine: current updates. N Am Spine Soc J (NASSJ). 2023; 16: 1-10. doi: 10.1016/j.xnsj.2023.100267.

  5. Cahueque M, Cobar A, Bregni M, Jiménez J. Síndrome de destrucción vertebral: del entendimiento a la práctica. Acta Ortop Mex. 2018; 32: 182-187.

  6. Yang P, Qu Y, Wang M. Pathogenesis and treatment of multiple mieloma. MedComm. 2020; 3: 1-27. doi: 10.1002/mco2.146.

  7. Jiménez J, del Toro J, Victoria C, Guerrero M. ¿Qué es el síndrome de destrucción vertebral? Orthotips. 2013; 9: 152-162.

  8. Aibar A, Martinez A, Castellote Y. Current status of the diagnosis and management of osteoporosis. Int J Mol Sci. 2022; 23: 2-10. doi: 10.3390/ijms23169465.

  9. Sobh M, Abdalbary M, Elnagar S, Nagy E. Secondary osteoporosis and metabolic bone diseases. J Clin Med. 2022; 11: 2382-2386. doi: 10.3390/jcm110923821.

  10. Urrutia J, Fuentealba F. Infecciones piógenas de la columna vertebral. Rev Med Clin Condes. 2020; 31: 448-455. doi: 10.1016/j.rmclc.2020.05.003.

  11. Mireles-Cano J, Escoto-Venegas E, García-González O, Miranda-González A, González-Ramírez J, Hernández-Sepúlveda E, et al. A management algorithm for vertebral destruction syndrome by multiple myeloma and metastatic spinal cord compression. Acta Ortop Mex. 2020; 34: 293-297. doi: 10.35366/97991.

  12. Rosales L, Valle I, Alpízar A, Miramontes V, Arenas M, Reyes A. Evaluación de la biopsia percutánea en el diagnóstico del síndrome de destrucción vertebral tóracico y lumbar. Cir Ciruj. 2007; 75: 459-463.

  13. Rosales L, Nieto H, Alpízar A, Zárate B, Sánchez M, Reyes A. Evaluación de la biopsia transpedicular guiada por TAC. Coluna/Columna. 2012; 11: 209-213. doi: 10.1590/S1808-18512012000300004.

  14. Rimondi E, Rossi G, Bartalena T, Ciminari R, Alberghini M, Ruggieri P, et al. Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2,027 cases. Eur J Radiol. 2011;77: 34-42. doi: 10.1016/j.ejrad.2010.06.055.

  15. Zarate-Kalfopulos B, García-Valerio J, Sánchez-Bringas G, Rosales-Olivares L, Alpízar-Aguirre A, Reyes-Sánchez A. Resultados de biopsia guiada por tomografía axial computarizada en el síndrome de destrucción vertebral, evaluados en dos instituciones distintas. Coluna/Columna. 2013; 12: 108-111. doi: 10.1590/S1808-18512013000200003.

  16. Alpízar-Aguirre A, Elías-Escobedo A, Rosales-Olivares L, Miramontes-Martínez V, Reyes Sánchez A. Síndrome de destrucción vertebral. Sistemas de evaluación en su diagnóstico. Cir Ciruj. 2008; 76: 205-211.

  17. Alpízar-Aguirre A, Rosales-Olivares L, Sanchez-Bringas G, Zárate-Kalfopulos B, Escutia-García J, Reyes-Sánchez A. Evaluación de una nueva sistematización de estudios para el diagnóstico del síndrome de destrucción vertebral. Coluna/Columna. 2012; 11: 151-155. doi: 10.1590/S1808-18512012000200013.




2020     |     www.medigraphic.com